Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-4 Infected Patients in Egypt

REFERENCES

• Kamal SM, and Nasser IA: Hepatitis C genotype 4: What we know and what we don’t yet know. Hepatology 47, 1371–1383, 2008.
   PubMed Web of Science ®Google Scholar
• Ehlayel MS, Hazeima KA, Al-Mesaifri F, and Bener A: Camel milk: an alternative for cow's milk allergy in children. Allergy Asthma Proceeding 32, 255–258, 2011.
   PubMed Web of Science ®Google Scholar
• Cardoso RR, Santos RM, Cardoso CR, Carvalho MO: Consumption of camel milk by patients intolerant to lactose. A preliminary study. Review Allergy Mexican 57, 26–32, 2010.
   PubMedGoogle Scholar
• Al-Hammadi S, El-Hassan T, and Al-Reyami L: Anaphylaxis to camel milk in an atopic child. Allergy 65, 1623–1625, 2010.
   PubMed Web of Science ®Google Scholar
• Agrawal RP, Dogra R, Mohta N, Tiwari R, Singhal S, et al.: Beneficial effect of camel milk in diabetic nephropathy. Acta Biomedica 80, 131–134, 2009.
   PubMedGoogle Scholar
• Mohamad RH, Zekry ZK, Al-Mehdar HA, Salama O, El-Shaieb SE, et al.: Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice. Journal Medical Food 12, 461–465, 2009.
   PubMed Web of Science ®Google Scholar
• Al-Hashem F: Camel milk protects against aluminium chloride-induced toxicity in the liver and kidney of white albino rats. Am J Biochem Biotechnol 5, 98–108, 2009.
   Google Scholar
• Kamal AM, Salama OA, and El-Said KM: Changes in amino acids profile of camel milk protein during the early lactation. Int J Dairy.Sci 2, 226–234, 2007.
   Google Scholar
• Shah NP: Effects of milk-derived bioactives: an overview. British Journal Nutrition, 84, 3–10, 2000.
   PubMed Web of Science ®Google Scholar
• El-Agamy EI: Effect of heat treatment on camel milk proteins with respect to antimicrobial factors: a comparison with cow's and buffalo milk. Food Chemistry 68, 227–232, 2000.
   Web of Science ®Google Scholar
• Barłowska J, Szwajkowska M, Litwinczuk Z, and Kr'ol J: Nutritional value and technological suitability of milk from various animal species used for dairy production. Comprehensive Reviews in Food Science and Food Safety 10, 291–302, 2011.
   Web of Science ®Google Scholar
• Cohen MS, Britigan BE, French M, and Bean K: Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. American Journal Obstetrics & Gynecology 157, 1122–1125, 1987.
   PubMed Web of Science ®Google Scholar
• Harmsen MC, Swart PJ, de Bethune MP, Pauwels R, and De Clercq E: Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. Journal Infectious Diseases 172, 380–388, 1995.
   PubMed Web of Science ®Google Scholar
• Farnaud S, and Evans RW: Lactoferrin—a multifunctional protein with antimicrobial properties. Molecular Immunology 40, 395–405, 2003.
   PubMed Web of Science ®Google Scholar
• Sánchez L, Calvo M, and Brock JH: Biological role of lactoferrin. Archive Diseases Children 67, 657–661, 1992.
   PubMed Web of Science ®Google Scholar
• Marín E, Sánchez L, Pérez MD, Puyol P, and Calvo M: Effect of heat treatment on bovine lactoperoxidase activity in skim milk: kinetic and thermodynamic analysis. Journal Food Science 68, 89–93, 2003.
   Web of Science ®Google Scholar
• Almahdy O, El-Fakharany EM, El-Dabaa E, Ng TB, and Redwan EM: Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and HELA cell lines. Hepat Mon 11, 724–730, 2011.
   PubMed Web of Science ®Google Scholar
• El-Fakharany EM, Abedelbaky N, Haroun BM, Sánchez L, Redwan NA, et al.: Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma. Virol J 9, 201, 2012.
   PubMed Web of Science ®Google Scholar
• El-Fakharany EM, Sánchez L, Al-Mehdar HA, and Redwan EM: Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study. Virol J 10, 199, 2013.
   PubMed Web of Science ®Google Scholar
• Korashy HM, Maayah ZH, Abd-Allah AR, El-Kadi AO, and Alhaider AA: Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. J Biomed Biotechnol 59, 3195, 2012.
   Google Scholar
• Abbas S, Imran R, AaliaNazir A, Qamar MF, and Sarfraz L: Effect of camel milk supplementation on blood parameters and liver function of hepatitis patients. American Journal of Ethnomedicine 1(3), 129–146, 2014.
   Google Scholar
• Scott JD, and Gretch DR: Molecular diagnostics of hepatitis C virus infection: A systematic review. JAMA 297, 724–732, 2007.
   PubMed Web of Science ®Google Scholar
• Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, et al.: Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes 104, 289–292, 1996.
   PubMed Web of Science ®Google Scholar
• Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, and Mosmann TR: Interleukin-10. Ann Rev Immunol 11, 165–190, 1993.
   PubMed Web of Science ®Google Scholar
• Beall CJ, Mahajan S, and Kolattukudy PE: Conversion of monocyte chemoattractant protein-1 into a neutrophil attractant by substitution of two amino acids. Journal of Biological Chemistry 267, 3455–3459, 1992.
   PubMed Web of Science ®Google Scholar
• Palanive MG, Rajkapoor B, Kumar RS, Einstein JW, Kumar EP, et al.: Hepatoprotective and antioxidant effect of Pisonia Aculeata L. against CCl4-induced hepatic damage in rats. Sci Pharm 76, 203–215, 2008.
   Google Scholar
• Thabrew M, Joice PD, and Rajatissa W: A comparative study of the efficacy of pavetta indica and osbeckia octandra in the treatment of liver dysfunction. Planta Med 53, 239–241, 1987.
   PubMed Web of Science ®Google Scholar
• Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, et al.: Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 8, 40, 2008.
   PubMed Web of Science ®Google Scholar
• Khan AA, and Alzohairy MA: Hepatoprotective effects of camel milk against CCl-4–induced hepatotoxicity in rats. Asian J Biochem 6, 171–180, 2011.
   Google Scholar
• Al-Fartosi KG, Majid A, Auda MA, and Hussein MH: The role of Camel’s milk against some oxidant-antioxidant markers of male rats treated with CCL4. Int J Res Pharmaceut Biomed Sci 3, 385–389, 2012.
   Google Scholar
• Yousef MI: Aluminum-induced changes in hematobiochemical parameters, lipid peroxidation and enzyme activities of male rabbits: protective role of ascorbic acid. Toxicol 199, 47–57, 2004.
   PubMed Web of Science ®Google Scholar
• Al-Humaid AI, Mousa HM, El-Mergawi RA, and Abel- Salam AM: Chemical composition and antioxidant activity of dates and dates- camel milk mistures as a protective meal against lipid peroxidation in rats. Am J Food Technol 5, 22–30, 2010.
   Google Scholar
• Abu-Lebdeh HS, and Nair KS: Protein metabolism in diabetes mellitus. Billieres Clin. Endocrinol. Metab 10, 589–601, 1996.
   PubMed Web of Science ®Google Scholar
• Hamad EM, Abdel Rahim EA, and Romeih EA: Beneficial effect of camel milk on liver and kidneys function in diabetic Sprague-Dawley rats. International Journal of Dairy Science 6, 190–197, 2011.
   Google Scholar
• Chen CH, Lin ST, Kuo CL, and Nien CK: Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma. Hepatogastroenterology 55, 1423–1427, 2008.
   PubMed Web of Science ®Google Scholar
• Emokpae MA, Adejumol BG, Abdu A, and Sadiq NM: Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients. Niger Med J 54, 426–429, 2013. doi:10.4103/0300-1652.126302.
   PubMedGoogle Scholar
• Tai WC, Hu TH, Wang, JH, Hung CH, Lu SN, et al.: Clinical implications of a-fetoprotein in chronic hepatitis C. J Formosa Med Assoc 108, 210–218, 2009.
   PubMed Web of Science ®Google Scholar
• Abu Mouch S, Fireman Z, Jarchovsky J, Zeina AR, and Assy N: Vitamin D supplement improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 17, 5184–5190, 2011.
   PubMed Web of Science ®Google Scholar
• Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, et al.: Low Vitamin D serum level is related to severe fibrosis and low responsiveness to IFN-based therapy in genotype I chronic hepatitis C. Hepatology 51, 1158–1167, 2010.
   PubMed Web of Science ®Google Scholar
• El Husseiny NM, Fahmy HM, Mohamed WA, and Amin HH: Relationship between vitamin D and IL-23, IL-17, and MCP-1 as markers of fibrosis in hepatitis C+ Egyptians. World J Hepatol 4, 242–247, 2012.
   PubMedGoogle Scholar
• Schaalan MF, Mohamed WA, and Amin HH: Vitamin D deficiency: Correlation to IL-17, IL-23, and PIIINP in hepatitis C virus genotype 4. World J Gastroenterol 18, 3738–3744, 2012.
   PubMed Web of Science ®Google Scholar
• Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, et al.: Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to IFNγ-based therapy. J Hepatol 54, 887–893, 2011.
   PubMed Web of Science ®Google Scholar
• Holick MF, and Chen TC: Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87, 1080S–1086S, 2008.
   PubMed Web of Science ®Google Scholar
• Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, et al.: Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to IFNγ-based therapy. J Hepatol 54, 887–893, 2011.
   PubMed Web of Science ®Google Scholar
• Deluca HF, and Cantorna MT: Vitamin D: Its role and uses in immunology. FASEB J. 15, 2579–2585, 2001.
   PubMed Web of Science ®Google Scholar
• Bialecki ES, and Di Bisceglie AM: Clinical presentation and natural course of hepato-cellular carcinoma. Eur J Gastroenterol Hepatol 17, 485–489, 2005.
   PubMed Web of Science ®Google Scholar
• Steib CJ, Gerbes AL, Bystron M, Op den Winkel M, Härtl J, et al.: Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2. J Hepatol 47, 228–238, 2007.
   PubMed Web of Science ®Google Scholar
• Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, et al.: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 22, 22–26, 1995.
   PubMed Web of Science ®Google Scholar
• Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, et al.: Transforming growth factor beta 1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 11, 1929–1936, 2005.
   PubMed Web of Science ®Google Scholar
• Lindqvist U, and Laurent TC: Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 52, 613–621, 1992.
   PubMed Web of Science ®Google Scholar
• Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, et al.: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 22, 22–26, 1995.
   PubMed Web of Science ®Google Scholar
• Gibson PR, Fraser JR, Brown TJ, Finch CF, Jones PA, et al.: Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 15, 1054–1059, 1992.
   PubMed Web of Science ®Google Scholar
• Poupon RE, Balkau B, Guechot J, and Heintzmann F: Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology 19, 635–640, 1994.
   PubMed Web of Science ®Google Scholar
• Korner T, Kropf J, and Gressner AM: Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 25, 684–688, 1996.
   PubMed Web of Science ®Google Scholar
• Liu R-M, and Gaston Pravia KA: Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic Biol Med 48, 1, 2010.
   Web of Science ®Google Scholar
• Perlemuter G, Letteron P, Carnot F, Zavala F, Pessayre D, et al.: Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 39, 1020–1027, 2003.
   PubMed Web of Science ®Google Scholar
• Samuele De Minicis DAB: Oxidative stress in alcoholic liver disease: Role of NADPH oxidase complex. Journal of Gastroenterology and Hepatology 23, S98–S103, 2008.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, et al.: Oxidation of extracellular cysteine/cystine redox state in bleomycininduced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 296, L37–L45, 2009.
   PubMed Web of Science ®Google Scholar
• Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, et al.: Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 200, 377–389, 2004.
   PubMed Web of Science ®Google Scholar
• Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, et al.: Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 49, 965–976, 2008.
   PubMed Web of Science ®Google Scholar
• Albright CD, Salganik RI, Craciunescu CN, Mar MH, and Zeisel SH: Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor-beta1 in immortalized rat hepatocytes. J Cell Biochem 89, 254–261, 2003.
   PubMed Web of Science ®Google Scholar
• Herrera B, Alvarez AM, Sanchez A, Fernandez M, Roncero C, et al.: Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J 15, 741–751, 2001.
   PubMed Web of Science ®Google Scholar
• Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, et al.: Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 152, 423–430, 1998.
   PubMed Web of Science ®Google Scholar
• Gu L, Tseng S, Horner RM, Tam C, Loda M, et al.: Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407–411, 2000.
   PubMed Web of Science ®Google Scholar
• Díaz-Valdés N, Basagoiti M, Dotor J, Aranda F, Monreal I, et al.: Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression. Cancer Res 71, 812–821, 2011.
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Ye L, Chen W, and Yu X: Smad7 inhibits TGF-β1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells. Int Urol Nephrol 45, 899–907, 2013.
   PubMed Web of Science ®Google Scholar